Zura Bio Ltd (94E.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
At close: 08:02AM CEST
| Previous Close | 4.3200 |
| Open | 4.2200 |
| Bid | 4.3200 x N/A |
| Ask | 4.4600 x N/A |
| Day's Range | 4.2200 - 4.2200 |
| 52 Week Range | 1.8700 - 11.3000 |
| Volume | |
| Avg. Volume | 5 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Zura Bio Ltd (ZURA) Q1 2024 Earnings: Financial and Strategic Developments
Insights into Zura Bio's First Quarter Financial Results and Future Outlook
Business WireZura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
HENDERSON, Nev., May 09, 2024--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported its first quarter 2024 financial results, and recent business highlights.
GuruFocus.comDirector Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA)
Director Amit Munshi has recently increased his stake in Zura Bio Ltd (NASDAQ:ZURA) by purchasing 159,744 shares of the company, as per the SEC Filing dated 2024-04-22.
© 2024 Yahoo. All rights reserved.